Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 26 | $5,080,509 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 20 Aug 2024 16:27 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 19 Aug 2024 | Sale | 305 | 46 | 14,030 | D |
| 20 Aug 2024 16:27 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 19 Aug 2024 | Sale | 2,400 | 45.01 | 108,024 | D |
| 11 Jun 2024 19:34 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Jun 2024 | Sale | 1,823 | 31.34 | 57,133 | D |
| 17 May 2024 21:03 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 16 May 2024 | Sale | 495 | 28.59 | 14,152 | D |
| 17 May 2024 21:03 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 16 May 2024 | Sale | 2,279 | 28.2 | 64,268 | D |
| 13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Mar 2024 | Sale | 1,776 | 25.71 | 45,661 | D |
| 13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Mar 2024 | Sale | 17,825 | 25.48 | 454,181 | D |
| 13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 08 Mar 2024 | Sale | 689 | 27.31 | 18,817 | D |
| 13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 08 Mar 2024 | Sale | 54,648 | 26.72 | 1,460,195 | D |
| 13 Mar 2024 06:04 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 08 Mar 2024 | Sale | 34,663 | 25.46 | 882,520 | D |
| 11 Mar 2024 21:50 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 07 Mar 2024 | Sale | 2,434 | 25.85 | 62,919 | D |
| 01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 01 Mar 2024 | Sale | 1,442 | 29.7 | 42,827 | D |
| 01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 01 Mar 2024 | Sale | 8,715 | 29.06 | 253,258 | D |
| 01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 01 Mar 2024 | Sale | 14,103 | 28.25 | 398,410 | D |
| 01 Mar 2024 21:37 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 29 Feb 2024 | Sale | 4,268 | 27.5 | 117,370 | D |
| 26 Jan 2024 19:48 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 26 Jan 2024 | Sale | 178 | 25.14 | 4,475 | D |
| 26 Jan 2024 19:48 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 26 Jan 2024 | Sale | 19,822 | 24.52 | 486,035 | D |
| 04 Jan 2024 21:47 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 04 Jan 2024 | Sale | 2,009 | 18.04 | 36,242 | D |
| 04 Jan 2024 21:47 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 03 Jan 2024 | Sale | 10,300 | 19.03 | 196,009 | D |
| 04 Jan 2024 21:47 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 03 Jan 2024 | Sale | 7,691 | 18.34 | 141,053 | D |
| 04 Jan 2024 21:47 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 02 Jan 2024 | Sale | 11,900 | 13.1 | 155,890 | D |
| 12 Dec 2023 17:34 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 11 Dec 2023 | Sale | 1,245 | 10.72 | 13,346 | D |
| 20 Sep 2023 16:49 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 18 Sep 2023 | Sale | 1,261 | 9.41 | 11,866 | D |
| 13 Sep 2023 19:53 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | Chief Business Officer | 12 Sep 2023 | Sale | 1,266 | 10.41 | 13,179 | D |
| 14 Jun 2023 18:40 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 13 Jun 2023 | Sale | 1,259 | 12.43 | 15,649 | D |
| 14 Jun 2023 18:40 | DYN | Dyne Therapeutics Inc | MCNEILL JONATHAN | See Remarks | 12 Jun 2023 | Sale | 1,000 | 13 | 13,000 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)